Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SineWave Ventures is an early-stage venture capital firm investing in technology companies with applications for both commercial enterprises and the public sector. It has invested in sectors such as cybersecurity, communications technology, aerospace/defense, industrial/manufacturing, and life sciences & healthcare. The firm closed its $160.3 million Fund III in 2023. While it invests in health IT and biotech startups at the seed and Series A stages, it does not itself conduct clinical trials or have a therapeutic pipeline. Notable investments include RunSafe Security (cybersecurity for critical infrastructure) and Anjuna Security (confidential computing), among others. The team operates from several locations including New York City; Alexandria, Virginia; Palo Alto; San Juan; and the San Francisco Bay Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SineWave Ventures.